Nephros Stock In The News

NEPH Stock  USD 2.10  0.07  3.45%   
The tone or emotional content of news articles related to Nephros can affect its prices. Positive news sentiment can lead to an increase in demand for Nephros' stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Nephros' news coverage and content from conventional and social sources shows investors' bearish mood towards Nephros. The specific impact of Nephros news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Nephros' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Nephros headlines in addition to utilizing other, more conventional financial analysis modules. Check out Nephros Backtesting and Nephros Hype Analysis.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.

Nephros Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Nephros Announces Results for Quarter Ended September 30, 2023
https://www.globenewswire.com/news-release/2023/11/08/2776734/0/en/Nephros-Announces-Results-for-Quarter-Ended-September-30-2023.html
 Neutral
Macroaxis News: globenewswire.com
Nephros Hires Judy Krandel as Chief Financial Officer
https://www.globenewswire.com/news-release/2023/11/01/2771020/0/en/Nephros-Hires-Judy-Krandel-as-Chief-Financial-Officer.html
 Bullish
Macroaxis News: globenewswire.com
Nephros Schedules Third Quarter 2023 Financial Results Conference Call
https://www.globenewswire.com/news-release/2023/10/25/2766388/0/en/Nephros-Schedules-Third-Quarter-2023-Financial-Results-Conference-Call.html
 Bullish
Macroaxis News: globenewswire.com
Nephros Announces Results for Quarter Ended June 30, 2023
https://www.globenewswire.com/news-release/2023/08/09/2722154/0/en/Nephros-Announces-Results-for-Quarter-Ended-June-30-2023.html
 Bullish
Macroaxis News: globenewswire.com
Nephros Schedules Second Quarter 2023 Financial Results Conference Call
https://www.globenewswire.com/news-release/2023/07/26/2711199/0/en/Nephros-Schedules-Second-Quarter-2023-Financial-Results-Conference-Call.html
 Bullish
Macroaxis News: globenewswire.com
Nephros Announces Results for Quarter Ended March 31, 2023
https://www.globenewswire.com/news-release/2023/05/10/2666081/0/en/Nephros-Announces-Results-for-Quarter-Ended-March-31-2023.html
 Neutral
Macroaxis News: globenewswire.com
Nephros Announces CEO Retirement and Succession Plan
https://www.globenewswire.com/news-release/2023/05/08/2663192/0/en/Nephros-Announces-CEO-Retirement-and-Succession-Plan.html
 Bullish
Macroaxis News: globenewswire.com
Nephros Schedules First Quarter 2023 Financial Results Conference Call
https://www.globenewswire.com/news-release/2023/04/26/2654919/0/en/Nephros-Schedules-First-Quarter-2023-Financial-Results-Conference-Call.html
 Bullish
Macroaxis News: globenewswire.com
Nephros Announces Preliminary Results for First Quarter 2023
https://www.globenewswire.com/news-release/2023/04/04/2640511/0/en/Nephros-Announces-Preliminary-Results-for-First-Quarter-2023.html
 Bullish
Macroaxis News: globenewswire.com
Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results
https://www.globenewswire.com/news-release/2023/03/08/2623531/0/en/Nephros-Announces-Fourth-Quarter-and-Fiscal-Year-2022-Financial-Results.html
 Neutral

Nephros Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Nephros and other traded companies coverage. We help investors stay connected with Nephros headlines for the 19th of April to make an informed investment decision based on correlating the impacts of news items on Nephros Stock performance. Please note that trading solely based on the Nephros hype is not for everyone as timely availability and quick action are needed to avoid losses.
Nephros' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Nephros investors visualize upcoming and past events in order to time the market based on Nephros noise-free hype analysis.
Nephros stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Nephros earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Nephros that are available to investors today. That information is available publicly through Nephros media outlets and privately through word of mouth or via Nephros internal channels. However, regardless of the origin, that massive amount of Nephros data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nephros news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nephros relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nephros' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nephros alpha.

Nephros Largest EPS Surprises

Earnings surprises can significantly impact Nephros' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-08-09
2023-06-30-0.05-0.040.0120 
2023-05-10
2023-03-31-0.02-0.03-0.0150 
2021-11-04
2021-09-30-0.1-0.12-0.0220 
2020-11-05
2020-09-30-0.14-0.120.0214 
2022-08-10
2022-06-30-0.15-0.120.0320 
2021-03-01
2020-12-31-0.11-0.080.0327 
View All Earnings Estimates

Nephros Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Nephros Stock. The global stock market is bearish. About 66% of major world exchanges and indexes are down. See today's market update for more information.
Google News at Macroaxis
15th of April 2024
GivBux Stock Price Up 31.9 percent - Defense World
at news.google.com 
Simply Wall St News at Macroaxis
20th of March 2024
Nephros Full Year 2023 Earnings Misses Expectations
at simplywall.st 
Macroaxis News
12th of March 2024
Acquisition by Arthur Amron of 7000 shares of Nephros at 2.4471 subject to Rule 16b-3
at MacroaxisInsider 
insidermonkey News
8th of March 2024
Nephros, Inc. Q4 2023 Earnings Call Transcript
at insidermonkey.com 
Yahoo News
7th of March 2024
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
at finance.yahoo.com 
Simply Wall St News at Macroaxis
29th of February 2024
Market Sentiment Around Loss-Making Nephros, Inc.
at simplywall.st 
Google News at Macroaxis
22nd of February 2024
Nephros, Inc. Revenue Breakdown NASDAQNEPH TradingView - TradingView
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nephros in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nephros' short interest history, or implied volatility extrapolated from Nephros options trading.
When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:
Check out Nephros Backtesting and Nephros Hype Analysis.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Nephros Stock analysis

When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.15)
Revenue Per Share
1.371
Quarterly Revenue Growth
0.272
Return On Assets
(0.09)
Return On Equity
(0.18)
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.